Cargando…
Computational validation of 3-ammonio-3-(4-oxido- 1H-imidazol-1-ium-5-yl) propane-1, 1-bis (olate) as a potent anti-tubercular drug against mt-MetAP
The advent of Multi Drug Resistant (MDR) strain of Mycobacterium tuberculosis (TB) necessitated search for new drug targets for the bacterium. It is reported that 3.3% of all new tuberculosis cases had multidrug resistance (MDR-TB) in 2009 and each year, about 0.44 million MDR-TB cases are estimated...
Autores principales: | Chowdhury, Abhishek, Sen, Shantanu, Dey, Pradip, Chetia, Pankaj, Talukdar, Anupam Das, Bhattacharjee, Amitabha, Choudhury, Manabendra Dutta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489093/ https://www.ncbi.nlm.nih.gov/pubmed/23144543 http://dx.doi.org/10.6026/97320630008875 |
Ejemplares similares
-
Crystal structure of 6-ethoxypyridin-1-ium-2-olate
por: Luo, Kaijun, et al.
Publicado: (2014) -
3-Ethyl-4-methyl-1H-pyrazol-2-ium-5-olate
por: Rathore, R. S., et al.
Publicado: (2011) -
1-(2,3-Dicyanophenyl)pyridin-1-ium-4-olate monohydrate
por: Han, Zhe, et al.
Publicado: (2013) -
(E)-1-(2-Phenyldiazen-2-ium-1-yl)naphthalen-2-olate
por: Bougueria, Hassiba, et al.
Publicado: (2013) -
Crystal structure of 2-ethyl-4-methyl-1-(2-oxido-3,4-dioxocyclobut-1-en-1-yl)-1H-imidazol-3-ium
por: Korkmaz, Ufuk, et al.
Publicado: (2016)